Nuvalent (NASDAQ:NUVL) Stock Price Expected to Rise, BMO Capital Markets Analyst Says

Source: Etfdailynews
Nuvalent (NASDAQ:NUVL – Free Report) had its target price upped by BMO Capital Markets from $132.00 to $134.00 in a research report report published on Wednesday,Benzinga reports. They currently have an outperform rating on the stock. NUVL has been the subject of a number of other reports. JPMorgan Chase & Co. upped their price target […]

Comments


View Article